Tag: Neurodegenerative diseases
Uncovering the Reality of Novel Alzheimer’s Medications
In early July, the US Food and Drug Administration (FDA) approved a new treatment called donanemab for individuals with early-stage Alzheimer’s disease. This medication is the second drug that has been proven to slow...
Advancements in Alzheimer’s Diagnosis: Are Doctors Prepared for New Blood Tests?
A new generation of blood tests is revolutionizing the diagnosis and treatment of Alzheimer's disease, according to doctors. These tests provide a quick and easy way for physicians to determine if a patient experiencing...
Improving Alzheimer’s Blood Tests for Diagnosis: Progress and Challenges
Alzheimer’s disease can be difficult to diagnose, but recent research suggests that proteins in the blood could offer a solution. At the annual Alzheimer’s Association International Conference in Philadelphia, new findings were presented, indicating...